• Je něco špatně v tomto záznamu ?

Oral supplementation with selected Lactobacillus acidophilus triggers IL-17-dependent innate defense response, activation of innate lymphoid cells type 3 and improves colitis

J. Hrdý, A. Couturier-Maillard, D. Boutillier, C. Lapadatescu, P. Blanc, J. Procházka, B. Pot, B. Ryffel, C. Grangette, M. Chamaillard

. 2022 ; 12 (1) : 17591. [pub] 20221020

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22033019

Live biotherapeutic products constitute an emerging therapeutic approach to prevent or treat inflammatory bowel diseases. Lactobacillus acidophilus is a constituent of the human microbiota with probiotic potential, that is illustrated by improvement of intestinal inflammation and antimicrobial activity against several pathogens. In this study, we evaluated the immunomodulatory properties of the L. acidophilus strain BIO5768 at steady state and upon acute inflammation. Supplementation of naïve mice with BIO5768 heightened the transcript level of some IL-17 target genes encoding for protein with microbicidal activity independently of NOD2 signaling. Of these, the BIO5768-induced expression of Angiogenin-4 was blunted in monocolonized mice that are deficient for the receptor of IL-17 (but not for NOD2). Interestingly, priming of bone marrow derived dendritic cells by BIO5768 enhanced their ability to support the secretion of IL-17 by CD4+ T cells. Equally of importance, the production of IL-22 by type 3 innate lymphoid cells is concomitantly heightened in response to BIO5768. When administered alone or in combination with Bifidobacterium animalis spp. lactis BIO5764 and Limosilactobacillus reuteri, BIO5768 was able to alleviate at least partially intestinal inflammation induced by Citrobacter rodentium infection. Furthermore, BIO5768 was also able to improve colitis induced by 2,4,6-trinitrobenzene sulfonic acid (TNBS). In conclusion, we identify a new potential probiotic strain for the management of inflammatory bowel diseases, and provide some insights into its IL-17-dependent and independent mode of action.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22033019
003      
CZ-PrNML
005      
20230131151718.0
007      
ta
008      
230120s2022 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-022-21643-0 $2 doi
035    __
$a (PubMed)36266398
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Hrdý, Jiří $u Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Centre d'Infection et d'Immunité de Lille, 59000, Lille, France $u Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
245    10
$a Oral supplementation with selected Lactobacillus acidophilus triggers IL-17-dependent innate defense response, activation of innate lymphoid cells type 3 and improves colitis / $c J. Hrdý, A. Couturier-Maillard, D. Boutillier, C. Lapadatescu, P. Blanc, J. Procházka, B. Pot, B. Ryffel, C. Grangette, M. Chamaillard
520    9_
$a Live biotherapeutic products constitute an emerging therapeutic approach to prevent or treat inflammatory bowel diseases. Lactobacillus acidophilus is a constituent of the human microbiota with probiotic potential, that is illustrated by improvement of intestinal inflammation and antimicrobial activity against several pathogens. In this study, we evaluated the immunomodulatory properties of the L. acidophilus strain BIO5768 at steady state and upon acute inflammation. Supplementation of naïve mice with BIO5768 heightened the transcript level of some IL-17 target genes encoding for protein with microbicidal activity independently of NOD2 signaling. Of these, the BIO5768-induced expression of Angiogenin-4 was blunted in monocolonized mice that are deficient for the receptor of IL-17 (but not for NOD2). Interestingly, priming of bone marrow derived dendritic cells by BIO5768 enhanced their ability to support the secretion of IL-17 by CD4+ T cells. Equally of importance, the production of IL-22 by type 3 innate lymphoid cells is concomitantly heightened in response to BIO5768. When administered alone or in combination with Bifidobacterium animalis spp. lactis BIO5764 and Limosilactobacillus reuteri, BIO5768 was able to alleviate at least partially intestinal inflammation induced by Citrobacter rodentium infection. Furthermore, BIO5768 was also able to improve colitis induced by 2,4,6-trinitrobenzene sulfonic acid (TNBS). In conclusion, we identify a new potential probiotic strain for the management of inflammatory bowel diseases, and provide some insights into its IL-17-dependent and independent mode of action.
650    _2
$a zvířata $7 D000818
650    _2
$a myši $7 D051379
650    _2
$a Bifidobacterium animalis $7 D000069982
650    12
$a kolitida $x chemicky indukované $x terapie $x mikrobiologie $7 D003092
650    _2
$a enterobakteriální infekce $x terapie $7 D004756
650    12
$a přirozená imunita $7 D007113
650    _2
$a zánět $7 D007249
650    12
$a idiopatické střevní záněty $x terapie $7 D015212
650    _2
$a interleukin-17 $7 D020381
650    12
$a Lactobacillus acidophilus $7 D007779
650    _2
$a lymfocyty $7 D008214
650    12
$a probiotika $x farmakologie $x terapeutické užití $7 D019936
650    _2
$a kyselina trinitrobenzensulfonová $x škodlivé účinky $7 D014302
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Couturier-Maillard, Aurélie $u INEM-UMR7355, Molecular Immunology, Institute of Infectious Diseases and Molecular Medicine (IDM), and Infectious Diseases, University and CNRS, Orléans, France
700    1_
$a Boutillier, Denise $u Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Centre d'Infection et d'Immunité de Lille, 59000, Lille, France
700    1_
$a Lapadatescu, Carmen $u Bioprox, 7 rue Aristide Briand, 92300, Levallois-Perret, France
700    1_
$a Blanc, Philippe $u Bioprox, 7 rue Aristide Briand, 92300, Levallois-Perret, France
700    1_
$a Procházka, Jan $u Institute of Molecular Genetics, Czech Centre for Phenogenomics, Czech Academy of Sciences, 252 50, Vestec, Czech Republic
700    1_
$a Pot, Bruno $u Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Centre d'Infection et d'Immunité de Lille, 59000, Lille, France $u Research Group of Industrial Microbiology and Food Biotechnology, Faculty of Sciences and Bioengineering Sciences, Vrije Universiteit Brussel, Brussels, Belgium
700    1_
$a Ryffel, Bernhard $u INEM-UMR7355, Molecular Immunology, Institute of Infectious Diseases and Molecular Medicine (IDM), and Infectious Diseases, University and CNRS, Orléans, France $u Division of Immunology and South African Medical Research Council (SAMRC) Immunology, Department of Clinical Immunology, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, 7925, Cape Town, RSA
700    1_
$a Grangette, Corinne $u Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Centre d'Infection et d'Immunité de Lille, 59000, Lille, France. corinne.grangette@pasteur-lille.fr
700    1_
$a Chamaillard, Mathias $u Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Centre d'Infection et d'Immunité de Lille, 59000, Lille, France. mathias.chamaillard@inserm.fr $u Univ. Lille, Inserm, U1003, 59000, Lille, France. mathias.chamaillard@inserm.fr
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 12, č. 1 (2022), s. 17591
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36266398 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131151714 $b ABA008
999    __
$a ok $b bmc $g 1891656 $s 1184354
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 12 $c 1 $d 17591 $e 20221020 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20230120

Najít záznam

Citační ukazatele

Možnosti archivace